These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22374926)

  • 21. Remarks by the Honorable Paul Rogers at the twentieth anniversary celebration of the 1976 Medical Device Amendments.
    Rogers PG
    Food Drug Law J; 1996; 51(4):505-7. PubMed ID: 11797728
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-24. PubMed ID: 21374838
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical device technology user fees.
    Bailey PG
    Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM
    Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical device regulation for manufacturers.
    McAllister P; Jeswiet J
    Proc Inst Mech Eng H; 2003; 217(6):459-67. PubMed ID: 14702983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From regulation to registration. Safety and performance needs drive industry consensus on voluntary servicing, remarketing controls.
    Hatem MB
    Biomed Instrum Technol; 1999; 33(5):393-8. PubMed ID: 10511908
    [No Abstract]   [Full Text] [Related]  

  • 28. Advice for healthcare facilities as MDDS manufacturers.
    Biomed Instrum Technol; 2011; Suppl():19. PubMed ID: 21992039
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
    Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. User fees and medical device reviews.
    Lewis C
    FDA Consum; 2003; 37(2):18-9. PubMed ID: 12715765
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(195):52602-62. PubMed ID: 10168287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Sep; 65(187):57726-32. PubMed ID: 11503643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vioxx, radiology, and the Food and Drug Administration.
    Pentecost MJ
    J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
    [No Abstract]   [Full Text] [Related]  

  • 35. Inappropriate attack on device development.
    Somberg JC
    Am J Ther; 2011; 18(2):91. PubMed ID: 21393999
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmaceuticals and medical devices: medical devices. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-25. PubMed ID: 20217916
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical device regulation in the United States and the European Union: a comparative study.
    Chai JY
    Food Drug Law J; 2000; 55(1):57-80. PubMed ID: 12296349
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical devices; gastroenterology-urology devices; nonimplanted, peripheral electrical continence device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(68):18236-7. PubMed ID: 11010624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.
    Mottes LM
    Seton Hall Law Rev; 2011; 41(2):723-63. PubMed ID: 21739761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.